| Senores Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544319 |
NSE Symbol : SENORES |
P/E(TTM) : 274.26 |
|
ISIN Demat : INE0RB801010 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.99 |
|
Book Value(₹) : 155.06 |
Market Cap(₹Cr) : 3,776.62 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 16.53 | 20.92 | 15.49 | 11.86 | 9.59 | 9.63 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 16.53 | 20.92 | 15.49 | 11.86 | 9.59 | 9.63 |
| Other Operating Income | 12.23 | 14.41 | 4.33 | 0.00 | 0.00 | 0.00 |
| Other Income | 9.78 | 11.36 | 8.39 | 9.25 | 7.19 | 3.09 |
| Total Income | 38.54 | 46.69 | 28.21 | 21.11 | 16.78 | 12.72 |
| Total Expenditure | 29.69 | 33.81 | 20.98 | 14.60 | 12.01 | 10.97 |
| PBIDT | 8.85 | 12.88 | 7.23 | 6.51 | 4.77 | 1.75 |
| Interest | 1.75 | 1.58 | 1.76 | 2.35 | 2.70 | 0.68 |
| PBDT | 7.10 | 11.30 | 5.47 | 4.16 | 2.07 | 1.07 |
| Depreciation | 3.58 | 3.65 | 1.88 | 1.27 | 0.75 | 0.53 |
| Tax | 0.56 | 1.02 | 0.39 | 0.48 | 0.28 | 0.41 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.31 | 0.20 | 0.50 | 0.40 | -0.03 | -0.17 |
| Reported Profit After Tax | 2.65 | 6.43 | 2.70 | 2.01 | 1.07 | 0.30 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.65 | 6.43 | 2.70 | 2.01 | 1.07 | 0.30 |
| EPS (Unit Curr.) | 1.98 | 1.40 | 0.59 | 0.39 | 0.32 | 0.09 |
| EPS (Adj) (Unit Curr.) | 1.98 | 1.40 | 0.59 | 0.39 | 0.32 | 0.09 |
| Calculated EPS (Unit Curr.) | 0.58 | 1.40 | 0.59 | 0.44 | 0.23 | 0.09 |
| Calculated EPS (Adj) (Unit Curr.) | 0.58 | 1.40 | 0.59 | 0.44 | 0.23 | 0.09 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.30 | 5.59 | 2.35 | 1.75 | 0.93 | 0.36 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.30 | 5.59 | 2.35 | 1.75 | 0.93 | 0.36 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 46.05 | 46.05 | 46.05 | 46.05 | 46.05 | 33.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.01 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 53.54 | 61.57 | 46.68 | 54.89 | 49.74 | 18.17 |
| PBDTM(%) | 42.95 | 54.02 | 35.31 | 35.08 | 21.58 | 11.11 |
| PATM(%) | 16.03 | 30.74 | 17.43 | 16.95 | 11.16 | 3.12 |